MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$267,849K Collaboration receivables$15,000K Prepaid assets$2,578K Other current assets$138K Total current assets$285,565K Property and equipment,net$4,337K Right-of-use asset$2,043K Restricted cash$415K Total assets$292,360K Total liabilities andstockholders' equity / former...$292,360K Total stockholders'equity / former...$234,104K Total liabilities$58,256K Additional paid-in capital$221,960K Retained earnings$12,128K Common stock, 0.001 parvalue 400,000,000...$16K Deferred revenue, net ofcurrent portion$36,351K Total currentliabilities$21,905K Deferred revenue,current portion$9,344K Accrued liabilities$6,983K Lease liabilities$2,680K Accrued compensation$2,091K Accounts payable$807K
Balance Sheet
source: myfinsight.com

Avidity Biosciences, Inc. (RNA)

Avidity Biosciences, Inc. (RNA)